Canada · Health Canada Drug Product Database
BLISTEX DCT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42607
- DIN
- 02157292
- Form
- Ointment
- Company as listed by source
- BLISTEX CORPORATION
- Source status
- Marketed (2014-02-13)
- Source last updated
- 2026-06-22
Source-listed ingredients
- OCTINOXATE — 7.3 %
- OXYBENZONE — 4.5 %
- MENTHOL — 0.6 %
- PHENOL — 0.48 %
- CAMPHOR — 0.38 %
These values do not establish equivalence or a dose recommendation.
Packages
- 7g/Jar
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →